Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Inhibitory role for GABA in autoimmune inflammation
Roopa Bhat a , 1 ,
Robert Axtell a ,
Ananya Mitra b ,
Melissa Miranda a ,
Christopher Lock a ,
Richard W. Tsien b , and
Lawrence Steinman a
aDepartment of Neurology and Neurological Sciences and bDepartment of Molecular and Cellular Physiology, Beckman Center for Molecular Medicine, Stanford University, Stanford, CA 94305
Contributed by Richard W. Tsien, December 31, 2009 (sent for review November 30, 2009)
Abstract:
GABA, the principal inhibitory neurotransmitter in the adultbrain, has a parallel inhibitory role in the immune system.We demonstrate that immune cells synthesize GABA and have themachinery for GABA catabolism. Antigen-presenting cells (APCs)express functional GABA receptors and respond electrophysiologicallyto GABA. Thus, the immune system harbors all of the necessaryconstituents for GABA signaling, and GABA itself may functionas a paracrine or autocrine factor. These observations led usto ask further whether manipulation of the GABA pathway influencesan animal model of multiple sclerosis, experimental autoimmuneencephalomyelitis (EAE). Increasing GABAergic activity amelioratesongoing paralysis in EAE via inhibition of inflammation. GABAergicagents act directly on APCs, decreasing MAPK signals and diminishingsubsequent adaptive inflammatory responses to myelin proteins.
Author contributions: R.B., R.A., A.M., C.L., and L.S. designedresearch; R.B., R.A., A.M., and M.M. performed research; R.B.,R.A., A.M., and M.M. analyzed data; and R.B., R.A., A.M., C.L.,R.W.T., and L.S. wrote the paper.
1To whom correspondence may be addressed. E-mail: roopa.bhat{at}stanford.edu. or rwtsien{at}stanford.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (16 February 2010) Sci. Signal.3 (109), ec54.
[DOI: 10.1126/scisignal.3109ec54] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort.
E. Obiora, R. Hubbard, R. D. Sanders, and P. R. Myles (2013)
Thorax
68, 163-170
|Abstract »|Full Text »|PDF »
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
L. Steinman, R. C. Axtell, D. Barbieri, R. Bhat, S. E. Brownell, B. A. de Jong, S. E. Dunn, J. L. Grant, M. H. Han, P. P. Ho, et al. (2013)
Multiple Sclerosis Journal
19, 5-14
|Abstract »|Full Text »|PDF »
Inflammation inhibits GABA transmission in multiple sclerosis.
S. Rossi, V. Studer, C. Motta, V. De Chiara, F. Barbieri, G. Bernardi, and D. Centonze (2012)
Multiple Sclerosis Journal
18, 1633-1635
|Abstract »|Full Text »|PDF »
Neuroactive steroids, their metabolites, and neuroinflammation.
S. Giatti, M. Boraso, R. C. Melcangi, and B. Viviani (2012)
J. Mol. Endocrinol.
49, R125-R134
|Abstract »|Full Text »|PDF »
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
M. H. Han, D. H. Lundgren, S. Jaiswal, M. Chao, K. L. Graham, C. S. Garris, R. C. Axtell, P. P. Ho, C. B. Lock, J. I. Woodard, et al. (2012)
J. Exp. Med.
209, 1325-1334
|Abstract »|Full Text »|PDF »
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity.
C. Prado, F. Contreras, H. Gonzalez, P. Diaz, D. Elgueta, M. Barrientos, A. A. Herrada, A. Lladser, S. Bernales, and R. Pacheco (2012)
J. Immunol.
188, 3062-3070
|Abstract »|Full Text »|PDF »
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
S. Rossi, R. Mancino, A. Bergami, F. Mori, M. Castelli, V. De Chiara, V. Studer, G. Mataluni, G. Sancesario, V. Parisi, et al. (2011)
Multiple Sclerosis Journal
17, 1301-1312
|Abstract »|Full Text »|PDF »
Impaired neurosteroid synthesis in multiple sclerosis.
F. Noorbakhsh, K. K. Ellestad, F. Maingat, K. G. Warren, M. H. Han, L. Steinman, G. B. Baker, and C. Power (2011)
Brain
134, 2703-2721
|Abstract »|Full Text »|PDF »
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease.
J. T. Dudley, M. Sirota, M. Shenoy, R. K. Pai, S. Roedder, A. P. Chiang, A. A. Morgan, M. M. Sarwal, P. J. Pasricha, and A. J. Butte (2011)
Science Translational Medicine
3, 96ra76
|Abstract »|Full Text »|PDF »
Systemic augmentation of {alpha}B-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.
A. Arac, S. E. Brownell, J. B. Rothbard, C. Chen, R. M. Ko, M. P. Pereira, G. W. Albers, L. Steinman, and G. K. Steinberg (2011)
PNAS
108, 13287-13292
|Abstract »|Full Text »|PDF »
GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes.
N. Soltani, H. Qiu, M. Aleksic, Y. Glinka, F. Zhao, R. Liu, Y. Li, N. Zhang, R. Chakrabarti, T. Ng, et al. (2011)
PNAS
108, 11692-11697
|Abstract »|Full Text »|PDF »
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging.
O. Albayram, J. Alferink, J. Pitsch, A. Piyanova, K. Neitzert, K. Poppensieker, D. Mauer, K. Michel, A. Legler, A. Becker, et al. (2011)
PNAS
108, 11256-11261
|Abstract »|Full Text »|PDF »
Critical appraisal of animal models of multiple sclerosis.
D. Baker, W. Gerritsen, J. Rundle, and S. Amor (2011)
Multiple Sclerosis Journal
17, 647-657
|Abstract »|Full Text »|PDF »